Surgically Targeted Radiation Therapy (STaRT) for patients with operable brain tumors

Placed by a neurosurgeon at the time of resection, GammaTile Therapy gives patients a head STaRT in the fight against brain tumors, delaying tumor recurrence and potentially extending survival_[1]

Limits radiation exposure to healthy tissue, minimizing side effects, including hair loss_[1]

Assures 100% treatment compliance for all patients

Reduces patient and caregiver treatment burden in terms of time and travel

REFERENCES

1. Garcia, M.A., Turner, A. & Brachman, D.G. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview. J Neurooncol 166, 203–212 (2024). https://doi.org/10.1007/s11060-023-04523-z

GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. For full product and safety information, refer to the Instructions for Use.

Surgically Targeted Radiation Therapy (STaRT) for patients with operable brain tumors

Placed by a neurosurgeon at the time of resection, GammaTile Therapy gives patients a head STaRT in the fight against brain tumors, delaying tumor recurrence and potentially extending survival_[1]

How does GammaTile Therapy work?

Are you a clinician interested in GammaTile Therapy?

Surgically Targeted Radiation Therapy (STaRT) for patients with operable brain tumors

Placed by a neurosurgeon at the time of resection, GammaTile Therapy gives patients a head STaRT in the fight against brain tumors, delaying tumor recurrence and potentially extending survival[1]

How does GammaTile Therapy work?

Are you a clinician interested in GammaTile Therapy?

Placed by a neurosurgeon at the time of resection, GammaTile Therapy gives patients a head STaRT in the fight against brain tumors, delaying tumor recurrence and potentially extending survival_[1]